Increasing patient engagement as a tool for improving care and outcomes has been a tough code to crack for the healthcare industry.
You've seen what the biggies can do. What about the smaller end of the spectrum? MM&M's second buyer's guide to pharma, healthcare, and life sciences consulting services focuses on the dos and don'ts of hiring boutique firms.
The healthcare marketing group made another major acquisition in the country last month.
Omnicom's healthcare revenue was up 2.7% in Q1
The 2018 MM&M/Publicis Health Diversity Survey is open.
Turett spent 25 years at Edelman before launching her own firm in 2013.
Alok Sonig, chief executive officer of developed markets at Dr. Reddy's Laboratories, articulates the benefits of generics.
With healthcare evolving from a fee-for-service system toward one that bases payment on outcomes, marketers must speak to customers in value-oriented messages.
Following massive strikes by Opdivo and Keytruda, will more supersized campaigns follow?
We considered pharma and healthcare ads that, per iSpotTV, started airing no earlier than January 2017.
MM&M is honoring 16 of the most-senior women in the healthcare industry along with 20 Women to Watch, aspiring healthcare commercial and marketing execs changing the face of the industry.
AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed
Caregivers and patients predict how the use of AI will affect them.
Walmart and Humana have started acquisition talks; Blue Cross and Blue Shield says opioids should not be the first treatment option to manage pain
What happens in the world of Facebook cannot be ignored in pharma marketing. It increasingly lives in a world of data that is highly sensitive and must be managed well.
PhRMA has released a series of new ads that blame high drug prices on cost increases to insurers and PBMs; Veterans Affairs Secretary Dr. David Shulkin has been fired; UK biotech Redx has suspended a Phase I/II trial of its cancer drug
Chris Palmer, president of CDM New York, shares his wake-up routine, what he's reading and his dream of owning a record store if he wasn't in the medical marketing field.
Industry opponents say the end is nigh for pharma's ability to deduct expenses for consumer drug advertising, but those who've found their calling in healthcare comms ought to have something to say about that.
The council, made up of seasoned pharma execs, will function as consultants to rbb's health clients and health team.
AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practiceMarch 21, 2018
The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.
MM&M has announced its annual showcase of executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.
There was so much bigger-picture coverage of pharma and healthcare in 2017 - pricing, Affordable Care Act reform and repeal - that it was easy to lose sight of everything else. PwC's Health Research Institute has used its annual look-ahead report to spotlight a handful of undercover trends.
As the evidence mounts that high-deductibles don't cause patients to shop or save for healthcare, payers are taking note.
At a time when value-based healthcare is a more common objective among stakeholders, EHR data can enable collaboration among payers, providers, health systems, and pharma manufacturers.
Opdivo hits key goal in late-stage trial; Philippines government sues Sanofi over anti-dengue vaccine; hospitals reach capacity amid record flu season.
Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts sayFebruary 01, 2018
Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.
Forget making incremental changes to the system. These three corporate giants are trying to change the model of U.S. healthcare itself.
Amazon, Berkshire Hathaway, and JPMorgan team up to form a healthcare company; Takeda's Zika vaccine receives FDA fast-track status
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
Takeda announces deals worth more than $1 billion; biotech and pharma investments reached $10.5 billion in 2017; prescriptions for nerve pain on the rise